[Pathologic conditions associated with drug-induced rhinitis].

Srp Arh Celok Lek

Zvezdara Department of Otorhinolaryngology, University Hospital Centre, Belgrade.

Published: August 2004

Rhinitis medicamentosa ("nose-drop-nose") is a term used for pathological condition of the nasal mucous membrane that results from long-term abuse with intranasal vasoconstrictors. The aim of this work was to examine what lead the patients with nosedropnose rhinitis to the initial usage of intranasal vasoactive drugs. In this prospective study, 92 patients with rhinitis medicamentosa were included. The evaluation of all study subjects comprised the history, ORL, microbiological and radiological examination, skin prick tests with a battery of routine respiratory and nutritive allergens and nasal cytology. The results of this study showed that the pathological conditions for initial use of intranasal vasoactive drugs were: acute upper respiratory infections in 29.3%, vasomotor rhinitis in 21.7%, allergic rhinitis in 16.3%, deviated nasal septum in 13.0%, nasal polyposis in 12%, rhinitis induced by mechanical trauma in 4.4%, and hormonal rhinitis in 3.3% of patients with rhinitis medicamentosa. In conclusion, the most common pathological conditions for developing rhinitis medicamentosa were chronic inflammatory and structural diseases manifested by permanent nasal obstruction as well as acute upper respiratory infections are.

Download full-text PDF

Source
http://dx.doi.org/10.2298/sarh0402014mDOI Listing

Publication Analysis

Top Keywords

rhinitis medicamentosa
16
rhinitis
9
intranasal vasoactive
8
vasoactive drugs
8
patients rhinitis
8
pathological conditions
8
acute upper
8
upper respiratory
8
respiratory infections
8
nasal
5

Similar Publications

Article Synopsis
  • Challenging adherence to positive airway pressure (PAP) therapy in patients with allergic rhinitis was highlighted in a case study of a 62-year-old male with obstructive sleep apnea (OSA) who struggled with PAP for ten years.
  • The combination of daily intranasal oxymetazoline and fluticasone significantly improved his tolerance and adherence to PAP therapy, unlike using fluticasone alone.
  • This approach may help enhance CPAP tolerance in patients with OSA and rhinitis, offering a promising area for future exploration to improve treatment adherence.
View Article and Find Full Text PDF

Outcomes after Functional Nasal Surgery in Patients with Versus without Rhinitis Medicamentosa.

Laryngoscope

October 2024

Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health, Detroit, Michigan, U.S.A.

Objective: Topical nasal decongestants (TNDs) are used to reduce nasal soft tissue edema and obstruction. However, after frequent TND use, patients can develop rhinitis medicamentosa (RM) with rebound nasal edema and obstruction. Management of RM has centered largely on TND cessation ± intranasal corticosteroids.

View Article and Find Full Text PDF

Rise and fall of decongestants in treating nasal congestion related diseases.

Expert Opin Pharmacother

October 2024

Department of Otorhinolaryngology & Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

Article Synopsis
  • Decongestants are medicines that help relieve stuffy noses caused by illnesses like colds and allergies.
  • This article reviews research to help doctors use decongestants safely and effectively for their patients.
  • It's important to use decongestants carefully and avoid buying products with unknown ingredients, as improper use can cause more problems.
View Article and Find Full Text PDF
Article Synopsis
  • - Sales of over-the-counter decongestant nasal sprays in Denmark have doubled from 2011 to 2023.
  • - Prolonged use of these sprays can lead to risks like rhinitis medicamentosa, a condition that worsens nasal congestion.
  • - There is a crucial need for better patient education on safe usage and side effects, along with more research to help health authorities regulate these products effectively.
View Article and Find Full Text PDF

Background: Rhinitis medicamentosa is a nonallergic inflammation of the nasal mucosa caused by topical decongestants overuse. It mainly affects young and middle-aged adults. Therefore, the aim of this study was to investigate the attitudes of pharmacists regarding the utilization of over-the-counter intranasal decongestants.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!